Skip to main content

Oral evidence transcripts

Science, Innovation and Technology Committee

Committee documents that were published online before May 2010 are available by session on the Pre-2010 Publications page.

Total results 354 (page 12 of 18)
16 March 2017
Inquiry Closing the STEM skills gap inquiry
Witnesses Yvonne Baker, Chief Executive Officer, STEM Learning UK, Paul Jackson, Chief Executive Officer, EngineeringUK, and Philip Pratley, Director, Trade and External Relations, Leonardo; Dr Kirsty Clode, Chair, Women into Manufacturing and Engineering, Blossom Hill, BAE Systems' UK Apprentice of the Year 2016, and Mark Page, Your Life Advisory Board Member and Managing Partner, A.T. Kearney
Oral Evidence
8 March 2017
Inquiry Genomics and genome-editing inquiry
Witnesses Dr Edward Hockings, Founder, Ethics and Genetics, Professor Michael Parker, Director, Ethox Centre, University of Oxford, and Non-executive Director and Chair, Ethics Advisory Committee, Genomics England, Peter Counter, Chief Information Officer and Project Manager, Genomics England, and Alison Hall, Head of Humanities, PHG Foundation; Professor Sir Mike Stratton, Director, Wellcome Trust Sanger Institute, and Chief Executive Officer, Wellcome Genome Campus, and Dr Jean Abraham, Academic Honorary Consultant in Medical Oncology, University of Cambridge
Oral Evidence
15 March 2017
Inquiry Setting up UK Research and Innovation: The Chief Executive role inquiry
Witnesses Professor Sir Mark Walport, Chief Executive Designate, UK Research and Innovation, and Rebecca Endean, Director, Research and Innovation Reform, Department for Business, Energy and Industrial Strategy
Oral Evidence
1 March 2017
Inquiry Ocean acidification inquiry
Witnesses Dr Carol Turley, Senior Scientist, Plymouth Marine Laboratory, Dr Alex Poulton, Principal Researcher in Marine Ecology and Biogeochemistry, National Oceanographic Centre, Dr Ceri Lewis, Senior Lecturer in Marine Biology, University of Exeter, and Dr Ned Garnett, Associate Director Research, Natural Environment Research Council; Dr Melody Clark, Project Leader, British Antarctic Survey, and Professor Nicholas Bates, Director of Research, Bermuda Institute of Ocean Sciences
Oral Evidence
22 February 2017
Inquiry Industrial Strategy: science, research and innovation inquiry
Witnesses Professor Alex Halliday, Vice President, Royal Society, Professor Quintin McKellar, Vice-Chancellor, University of Hertfordshire and Chair, Universities UK's Innovation and Growth Policy Network, and Professor Paul Nightingale, Deputy Director, Science Policy Research Unit, University of Sussex; Steve Bates, Chief Executive, BioIndustry Association, Jen Rae, Head of Policy, Nesta, and Allan Cook, Vice President, Royal Academy of Engineering
Oral Evidence
8 February 2017
Inquiry Genomics and genome-editing inquiry
Witnesses Professor Sue Hill, Chief Scientific Officer, NHS England, Professor Mark Caulfield, Chief Scientist, Genomics England, and Dr Julia Wilson, Associate Director, Wellcome Trust Sanger Institute; Professor Sir John Burn, Non-executive Director, NHS England, Professor Dame Kay Davies, Non-executive Director, Genomics England, and Dr Helen Firth, Clinical Lead, Deciphering Developmental Disorders Project, Wellcome Trust Sanger Institute
Oral Evidence
1 February 2017
Inquiry My Science Inquiry
Witnesses Sandy Starr, Communications Officer, Progress Educational Trust; Bob Ward, Policy and Communications Director, Grantham Research Institute on Climate Change and the Environment; Amanda Lyne, Chair, UK Hydrogen and Fuel Cell Association; Dr Bryn Jones; Dr Stephanie Mathisen, Campaigns and Policy Officer, Sense about Science; Professor John Finney, British Pugwash Group; Professor Shahin Rahimifard, Professor of Sustainable Engineering, Loughborough University; Dr Michael Brand, Sensor100; Professor Becky Parker, Director, Institute for Research in Schools
Oral Evidence
25 January 2017
Inquiry GO-Science Annual Report 2015-16 inquiry
Witnesses Professor Sir Mark Walport, Government Chief Scientific Adviser, and Dr Rupert Lewis, Director, Government Office for Science.
Oral Evidence
11 January 2017
Inquiry Managing intellectual property and technology transfer inquiry
Witnesses Joseph Johnson MP, Minister for Universities, Science, Research and Innovation, Jenny Dibden, Director of Science and Research, Department for Business, Energy and Industrial Strategy, and Sean Dennehey, Acting Chief Executive and Comptroller General, Intellectual Property Office.
Oral Evidence
14 December 2016
Inquiry Managing intellectual property and technology transfer inquiry
Witnesses Mark Anderson, The Law Society IP Law Committee, and Dr Daniel Nelki, Science to Health Lead, Wellcome Trust; Professor Dame Ann Dowling, President, Royal Academy of Engineering, and Professor Trevor McMillan, Vice-Chancellor, Keele University
Oral Evidence
7 December 2016
Inquiry Regenerative medicine inquiry
Witnesses Dr Nick Crabb, Programme Director, Scientific Affairs, National Institute for Health and Care Excellence, Dr Jonathan Fielden, Director of Specialised Commissioning and Deputy National Medical Director, NHS England, and Dr James Palmer, Clinical Director of Specialised Commissioning, NHS England; Professor Amit Nathwani, Professor of Haematology, Royal Free Hospital, Professor Giovanna Lombardi, Professor of Human Transplant Immunology, King’s College London, and Dr Anthony Mathur, Professor of Cardiology, Queen Mary’s School of Medicine and Dentistry; Lord Prior of Brampton, Parliamentary Under-Secretary of State for Health, Department of Health
Oral Evidence
30 November 2016
Inquiry Antimicrobial resistance follow up inquiry
Witnesses Lord O’Neill of Gatley, Helen Shirley-Quirk, Director, Emergency Preparedness and Health Protection Policy, Department of Health, Professor Paul Cosford, Director, Health Protection and Medical Director, Public Health England, and Simon Hall, Veterinary Director, Animal and Plant Health Agency
Oral Evidence
22 November 2016
Inquiry Managing intellectual property and technology transfer inquiry
Witnesses Dr Will West, Executive Chairman, CellCentric and Member, BioIndustry Association Board, Felicity Burch, Head of Innovation and Digital, CBI, and Richard North, Head of IP Protection Licensing and Control, Rolls-Royce; Anne Glover, Co-founder and Chief Executive, Amadeus Capital Partners Ltd, Chris Mairs, Venture Partner, Entrepreneur First, and Mike Conroy, Executive Director, Corporate and Commercial Banking, British Bankers’ Association
Oral Evidence
16 November 2016
Inquiry Science communication inquiry
Witnesses Dr Melanie Smallman, Department of Science and Technology Studies, University College London, and Professor Robert Evans, School of Social Sciences, Cardiff University; Joseph Johnson MP, Minister for Universities, Science, Research and Innovation, Department for Business, Energy and Industrial Strategy, and Professor Sir Mark Walport, Government Chief Scientific Adviser, Government Office for Science
Oral Evidence
2 November 2016
Inquiry Managing intellectual property and technology transfer inquiry
Witnesses Dr Tony Raven, Chief Executive, Cambridge Enterprise, Nick Sturge, Director, Engine Shed, University of Bristol, and Dr Claire Brady, Head of Technology Transfer, Edinburgh Research and Innovation, The University of Edinburgh; Dr Phil Clare, Chair, Advocacy Committee, PraxisUnico, Dr Rosa Fernández, Research Director, National Centre for Universities and Business, and Dr Toby Basey-Fisher, Chief Executive, Eva Diagnostics
Oral Evidence
26 October 2016
Inquiry Leaving the EU: implications and opportunities for science and research inquiry
Witnesses Mr Robin Walker MP, Parliamentary Under-Secretary of State, Department for Exiting the European Union, Jo Johnson MP, Minister for Universities, Science, Research and Innovation, and Gareth Davies, Director General, Business and Science, Department for Business, Energy and Industrial Strategy
Oral Evidence
19 October 2016
Inquiry Regenerative medicine inquiry
Witnesses Dr Ian Hudson, Chief Executive, Medicines and Healthcare Products Regulatory Agency, Professor Paul Whiting, Member, Medical Research Council Regenerative Medicine Research Committee, Dr Sven Kili, Head of Gene Therapy Development, GlaxoSmithKline, and Michael Hunt, Chief Financial Officer, ReNeuron Group; Ian Trenholm, Chief Executive, NHS Blood and Transplant, Ian McCubbin, Medicines Manufacturing Industry Partnership and co-chair of the Advanced Therapy Manufacturing Taskforce, Keith Thompson, Chief Executive Officer, Cell and Gene Therapy Catapult, and Dr Ruth McKernan, Chief Executive, Innovate UK
Oral Evidence
12 October 2016
Inquiry Role and priorities of UK Research and Innovation (UKRI) interim chair inquiry
Witnesses Sir John Kingman, Interim Chair, UK Research and Innovation, and Rebecca Endean, Director, Science and Research, Department for Business, Energy and Industrial Strategy
Oral Evidence
24 May 2016
Inquiry Robotics and artificial intelligence inquiry
Witnesses Dr Rob Buckingham, Director, RACE, Professor Stephen Muggleton, Association for the Advancement of Artificial Intelligence, Professor Nick Jennings, Royal Society Working Group on Machine Learning, and Professor Philip Nelson, Chair, Research Councils UK; Richard Moyes, Managing Partner, Article 36, and Dr Owen Cotton-Barratt, Research Fellow, Future of Humanity Institute
Oral Evidence
13 September 2016
Inquiry Science in emergencies: chemical, biological, radiological or nuclear incidents inquiry
Witnesses Gary Butler, Assurance Director, Atomic Weapons Establishment, Simon Earwicker, Division Head, Chemical, Biological and Radiological Sciences Division, and Dr Cerys Rees, Fellow, Chemical, Biological and Radiological Science Division, Defence Science and Technology Laboratory, and Dr Nick Gent, Deputy Head, Emergency Response Department, Public Health England; Ben Wallace MP, Minister for Security, Home Office, and Paul McCloghrie, Deputy Director, National Risks and Infrastructure, Civil Contingencies Secretariat
Oral Evidence
Total results 354 (page 12 of 18)